Clinical Trial Update: Collaborative Risk-stratified Investigation in Thrombosis-prone Inpatients With Critical Illness: Anticoagulation With LMWH in Teens for ThromboProphylaxis (CRITICAL-Teens-TP). [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating low-molecular-weight heparin for thromboprophylaxis in teens at risk of venous thromboembolism, currently not yet recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Low molecular weight heparin (low molecular weight heparin)

Snippet

Sponsor: Johns Hopkins All Children's Hospital | Conditions: Venous Thromboembolism (VTE) | Phase 3 | Status: NOT_YET_RECRUITING